India Seeks BRICS Markets to Offset US Tariff Impact on Generic Drugs

Source: अमर उजाला | Original Published At: 2026-07-24 00:01:02 UTC

Key Points

• US President Donald Trump has announced possible tariffs of 100% to 200% on Indian generic drugs in two years.
• At the 16th BRICS Health Ministers' Meeting in Chandigarh, India proposed a health cooperation roadmap supported by member countries.
• The cooperation covers affordable medicines, vaccines, medical products, digital health and Ayush.
• India is preparing bilateral agreements with BRICS member states, although no signing or implementation timeline has been set.
• If India captures 10% of BRICS and related emerging markets, generic drug exports could reach about $35 billion, compared with current exports of $9.7 billion to the US.
• IQVIA data cited in the article says Indian companies meet about 47% of US generic drug demand, and tariffs could raise costs for US patients, hospitals and insurers.
• The article highlights opportunities in Brazil, Russia, the United Arab Emirates, Egypt, Ethiopia, Indonesia, South Africa and other African markets.